DNA X, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
DNA X, Inc. (SONM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $110.52 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-19
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $225.30, a 4703.84% increase year-over-year.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $4.69, a 56.61% decline year-over-year.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $10.81.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was $119.47, a 91.21% decline from fiscal 2024.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $1358.46, a 2918.80% increase from fiscal 2023.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $45.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $110.52 10-Q · filed 2026-08-19 | ||||
| 2026-03-31 | $225.30 10-Q · filed 2026-05-20 | ||||
| 2025-12-31 | $119.47 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $116.18 10-Q · filed 2025-10-31 | ||||
| 2025-06-30 | $6.72 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | $4.69 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | $1358.46 10-K · filed 2026-04-15 | $75.47 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $99.29 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | $147.24 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | $10.81 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $45.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |